EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and validation of a high throughput multiplex immunofluorescence assay to detect all human immunoglobulin isotypes and subclasses in human fluids

Arthur H Van Stigt iD, Maaike Nederend iD, Gaby Smits iD, Marjan Kuijer iD, Rutger M Schepp iD, Pieter G Van Gageldonk iD, Anneke H Hellinga iD, Robert S Van Binnendijk iD, Louis J Bont, Belinda Van't Land iD, Gerco Den Hartog iD, Jeanette H W Leusen und 1 weitere

The Journal of Immunology · 01.04.2025 · 214 (4) · 839-849

DOI: 10.1093/jimmun/vkae048 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift The Journal of Immunology, online erschienen am 06.03.2025. Verfasst von Arthur H Van Stigt und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Milk, Human, Fluorescent Antibody Technique, Immunoglobulin Isotypes, High-Throughput Screening Assays. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Regio Deal food valley, Dutch ministry of Health, Welfare and Sport.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies in human milk protect infants against infections, but currently no assay is described that is able to simultaneously measure all 9 antibody isotypes and subclasses immunoglobulins in human fluids, such as human milk. Our cohort “Protecting against Respiratory tract Infections through human Milk Analysis” (PRIMA) is focused on the relation between the occurrence of respiratory infections during the first year of life and concentration of maternal antibodies in breastfeeding. We developed and successfully validated a multiplex assay that is able to measure all nine antibody isotypes and subclasses in human plasma and milk (regardeless of the pathogen specificity), using a small sample volume. We used a multiplex immunofluorescence assay (MIA) requiring a minimal sample volume of 25 µl. Commercially available human isotype standards were used in spiking experiments to exclude the presence of cross reactivity. In addition, we prevented signal quenching by milk by determining the optimal dilution of human milk. In conclusion, we have developed a low-volume multiplex assay, that, for the first time, can reliably quantify functionally intact antibodies of all known human isotypes and subclasses and that is able to measure both kappa and lambda heavy chain antibodies. This assay can easily be implemented in other academic labs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Milk, HumanFluorescent Antibody TechniqueImmunoglobulin IsotypesHigh-Throughput Screening AssaysHumansFemaleRespiratory Tract Infections

Stichwörter der Autor:innen

antibodieshumanmolecular biology

Substanzen

Immunoglobulin Isotypes

Autor:innen und Institutionen

  • Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
  • ReSViNET Foundation, Zeist, The Netherlands.
  • Danone Nutricia Research, Utrecht, The Netherlands.

ORCID-Profile: Arthur H Van Stigt, Maaike Nederend, Gaby Smits, Marjan Kuijer, Rutger M Schepp, Pieter G Van Gageldonk, Anneke H Hellinga, Robert S Van Binnendijk, Belinda Van't Land, Gerco Den Hartog

Förderung

  • Regio Deal food valley
  • Dutch ministry of Health
  • Welfare and Sport
  • Danone Nutricia Research
  • UMC Utrecht-Danone Nutricia Research
  • UMC Utrecht-Danone Nutricia Research BV
  • Early Life Nutrition and Immune Development

Zitieren

APA

Van Stigt, A. H., Nederend, M., Smits, G., Kuijer, M., Schepp, R. M., Van Gageldonk, P. G., Hellinga, A. H., Van Binnendijk, R. S., Bont, L. J., Van't Land, B., Den Hartog, G., Leusen, J. H. W., & PRIMA Initiative Group (2025). Development and validation of a high throughput multiplex immunofluorescence assay to detect all human immunoglobulin isotypes and subclasses in human fluids. The Journal of Immunology, 214(4), 839-849. https://doi.org/10.1093/jimmun/vkae048

Vancouver

Van Stigt AH, Nederend M, Smits G, Kuijer M, Schepp RM, Van Gageldonk PG, et al. Development and validation of a high throughput multiplex immunofluorescence assay to detect all human immunoglobulin isotypes and subclasses in human fluids. The Journal of Immunology. 2025;214(4):839-849. doi:10.1093/jimmun/vkae048

BibTeX
@article{VanStigt2025,
  author = {Van Stigt, Arthur H and Nederend, Maaike and Smits, Gaby and Kuijer, Marjan and Schepp, Rutger M and Van Gageldonk, Pieter G and Hellinga, Anneke H and Van Binnendijk, Robert S and Bont, Louis J and Van't Land, Belinda and Den Hartog, Gerco and Leusen, Jeanette H W and PRIMA Initiative Group, PRIMA Initiative Group},
  title = {Development and validation of a high throughput multiplex immunofluorescence assay to detect all human immunoglobulin isotypes and subclasses in human fluids},
  journal = {The Journal of Immunology},
  year = {2025},
  volume = {214},
  number = {4},
  pages = {839--849},
  doi = {10.1093/jimmun/vkae048}
}
Kostenlos starten →